Novo Integrated Sciences Price to Free Cash Flow Ratio 2012-2024 | NVOS
Historical price to free cash flow ratio values for Novo Integrated Sciences (NVOS) since 2012.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Novo Integrated Sciences Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2024-09-26 |
0.29 |
|
0.00 |
| 2024-05-31 |
1.05 |
$-0.33 |
0.00 |
| 2024-02-29 |
0.63 |
$-0.30 |
0.00 |
| 2023-11-30 |
1.20 |
$-0.27 |
0.00 |
| 2023-08-31 |
0.14 |
$-0.23 |
0.00 |
| 2023-05-31 |
0.13 |
$0.04 |
3.54 |
| 2023-02-28 |
0.13 |
$-1.12 |
0.00 |
| 2022-11-30 |
0.25 |
$-1.84 |
0.00 |
| 2022-08-31 |
1.67 |
$-2.09 |
0.00 |
| 2022-05-31 |
2.05 |
$-2.59 |
0.00 |
| 2022-02-28 |
1.39 |
$-1.45 |
0.00 |
| 2021-11-30 |
1.44 |
$-0.78 |
0.00 |
| 2021-08-31 |
1.82 |
$-0.52 |
0.00 |
| 2021-05-31 |
2.22 |
$-0.20 |
0.00 |
| 2021-02-28 |
5.21 |
$-0.13 |
0.00 |
| 2020-11-30 |
0.36 |
$-0.26 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.006B |
$0.013B |
|
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
|
